The transition of GLP-1 receptor agonists from injections to oral delivery is reshaping diabetes management, offering a more straightforward and less intrusive method of taking medication
In the control group, pretest and posttest scores were not significantly different (P = 0.392)
7,8 Weight loss is facilitated by a reduction in energy intake
Candidacy is a clinical decision made with a provider, not a checkbox
both can cause GI upset, so side effects may overlap
Caution: Details GLP-1R/GIPR/GCGR signaling and metabolic regulation Peptide hormones acting through the glucagon-like peptide-1 receptor ( GLP-1R ), the glucose-dependent insulinotropic polypeptide receptor ( GIPR ), and the glucagon receptor ( GCGR ) play complementary roles in the regulation of glucose metabolism and energy balance [1]